Epileptic Syndromes
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
The vast majority of mutations responsible for epilepsy syndromes such as genetic epilepsy with febrile seizures plus (GEFS+) and Dravet syndrome (DS) occur in the gene encoding the type 1 alpha subunit of neuronal voltage-gated sodium channel (SCN1A).
|
31765958 |
2020 |
Epileptic Syndromes
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
However, predicting the outcome of de novo missense SCN1A mutations is difficult, since milder epileptic syndromes may also be associated.
|
30735520 |
2019 |
Epileptic Syndromes
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Dravet syndrome is an intractable childhood epilepsy syndrome most often associated with an SCN1A mutation.
|
29031192 |
2017 |
Epileptic Syndromes
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Mutations in the SCN1A gene cause a spectrum of epilepsy syndromes.
|
28079431 |
2017 |
Epileptic Syndromes
|
0.100 |
Biomarker
|
disease |
BEFREE |
Evaluation of Presumably Disease Causing SCN1A Variants in a Cohort of Common Epilepsy Syndromes.
|
26990884 |
2016 |
Epileptic Syndromes
|
0.100 |
Biomarker
|
disease |
BEFREE |
Our goal was to determine whether SCN1A screening is relevant in patients with a broad range of epileptic syndromes.
|
27045673 |
2016 |
Epileptic Syndromes
|
0.100 |
Biomarker
|
disease |
BEFREE |
Therefore, we performed a genome-wide screening for copy number variations (CNVs) in 36 patients with SCN1A-negative fever-associated syndromic epilepsies.
|
25690317 |
2015 |
Epileptic Syndromes
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Mutations in the gene encoding the alpha subunit of the voltage-gated sodium channel SCN1A are associated with several epilepsy syndromes.
|
25795284 |
2015 |
Epileptic Syndromes
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Mutations in the SCN1A gene have commonly been associated with a wide range of mild to severe epileptic syndromes.
|
25590135 |
2015 |
Epileptic Syndromes
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Mutations in the gene encoding the α1 subunit of the voltage gated sodium channel (SCN1A) are associated with several epilepsy syndromes, ranging from relatively mild phenotypes found in families with genetic epilepsy with febrile seizures plus (GEFS+) to the severe infant-onset epilepsy Dravet syndrome.
|
24836964 |
2014 |
Epileptic Syndromes
|
0.100 |
Biomarker
|
disease |
BEFREE |
These findings suggest SCN1A involvement in a common epilepsy syndrome, give new direction to biological understanding of mesial temporal lobe epilepsy with hippocampal sclerosis with febrile seizures, and open avenues for investigation of prognostic factors and possible prevention of epilepsy in some children with febrile seizures.
|
24014518 |
2013 |
Epileptic Syndromes
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Dravet syndrome is a devastating infantile-onset epilepsy syndrome with cognitive deficits and autistic traits caused by genetic alterations in SCN1A gene encoding the α-subunit of the voltage-gated sodium channel Na(v)1.1.
|
23639079 |
2013 |
Epileptic Syndromes
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Mutations in the SCN1A gene are associated with a variety of epilepsy syndromes and more recently with familial hemiplegic migraine.
|
22550089 |
2013 |
Epileptic Syndromes
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
SCN1A mutations are associated with a variety of epilepsy syndromes; the more severe syndromes are associated with truncation or complete loss of function of the protein.
|
22905747 |
2012 |
Epileptic Syndromes
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
SCN1A gene mutations are linked to multiple epilepsy syndromes with patients frequently presenting with prolonged febrile seizures.
|
22532537 |
2012 |
Epileptic Syndromes
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Over 40 missense mutations in the human SCN1A sodium channel gene are linked to an epilepsy syndrome termed genetic epilepsy with febrile seizures plus (GEFS+).
|
23055484 |
2012 |
Epileptic Syndromes
|
0.100 |
Biomarker
|
disease |
BEFREE |
The SCN1A gene is a major gene in different epilepsies and epilepsy syndromes; the HRM could be the new methodology, more rapid and efficacious, for molecular analysis of the SCN1A gene.
|
21713554 |
2011 |
Epileptic Syndromes
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Mutations in the SCN1A gene can cause a variety of dominantly inherited epilepsy syndromes.
|
21775168 |
2011 |
Epileptic Syndromes
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
We propose a unified loss-of-function hypothesis for the spectrum of epilepsy syndromes caused by genetic changes in NaV1.1 channels, in which mild impairment predisposes to febrile seizures, intermediate impairment leads to GEFS+ epilepsy, and severe or complete loss of function leads to the intractable seizures and comorbidities of SMEI.
|
20194124 |
2010 |
Epileptic Syndromes
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Dravet syndrome (DS) or severe myoclonic epilepsy of infancy is an intractable epileptic syndrome that is caused by mutations in the neuronal voltage-gated sodium channel alpha1 subunit gene SCN1A.
|
20431604 |
2010 |
Epileptic Syndromes
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
In particular, the SCN1A gene coding for the pore-forming a-subunit of the voltage-gated sodium channel Na(V)1.1 appears to be a common target for epilepsy syndrome-specific mutations.
|
19666879 |
2009 |
Epileptic Syndromes
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Mutations in the NaV1.1 neuronal sodium channel alpha-subunit (SCN1A) gene have been documented in a spectrum of epilepsy syndromes, ranging from the relatively benign generalized epilepsy with febrile seizures plus (GEFS(+)) to severe myoclonic epilepsy in infancy (SMEI), and rare cases of familial migraine.
|
19469841 |
2009 |
Epileptic Syndromes
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
PubMed was searched for articles and information was extracted on localisation and types of SCN1A missense mutations in patients with benign and severe epileptic syndromes; detailed information was also extracted.
|
19586930 |
2009 |
Epileptic Syndromes
|
0.100 |
Biomarker
|
disease |
BEFREE |
Mutations in the SCN 1 A gene, encoding the neuronal voltage-gated sodium channel alpha1 subunit, cause SMEI, GEFS+, and related epileptic syndromes.
|
18031552 |
2008 |
Epileptic Syndromes
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
To search for disease-causing mutations in SCN1A in patients with cryptogenic epileptic syndromes (ie, syndromes with an unknown cause).
|
18413471 |
2008 |